Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

• Chunni Zhu,
• Tina Bilousova,
• Samantha Focht,
• Michael Jun,
• Chris Jean Elias,
• Mikhail Melnik,
• Sujyoti Chandra,
• Jesus Campagna,
• Whitaker Cohn,
• Asa Hatami,
• Patricia Spilman,
• Karen Hoppens Gylys,
• Varghese John

Affiliations

Chunni Zhu

Drug Discovery Lab, Department of Neurology, University of California

Tina Bilousova

Drug Discovery Lab, Department of Neurology, University of California

Samantha Focht

Drug Discovery Lab, Department of Neurology, University of California

Michael Jun

Drug Discovery Lab, Department of Neurology, University of California

Chris Jean Elias

Drug Discovery Lab, Department of Neurology, University of California

Mikhail Melnik

Drug Discovery Lab, Department of Neurology, University of California

Sujyoti Chandra

Drug Discovery Lab, Department of Neurology, University of California

Jesus Campagna

Drug Discovery Lab, Department of Neurology, University of California

Whitaker Cohn

Drug Discovery Lab, Department of Neurology, University of California

Asa Hatami

Drug Discovery Lab, Department of Neurology, University of California

Patricia Spilman

Drug Discovery Lab, Department of Neurology, University of California

Karen Hoppens Gylys

School of Nursing, University of California

Varghese John

Drug Discovery Lab, Department of Neurology, University of California